Contribution of PKB/AKT signaling to thyroid cancer

Giuseppe Viglietto1, Nicola Amodio, Donatella Malanga

  • 1Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, University Campus Germaneto, Catanzaro 88100, Italy. viglietto@unicz.it

Insights

The Akt signaling pathway is crucial for cell growth and survival, and its abnormal activation contributes to thyroid cancer development. This review explores Akt

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Signaling

Background:

  • The Akt (also known as Protein Kinase B or PKB) serine/threonine kinase family is a central signaling node activated by growth factors and cytokines.
  • Akt regulates fundamental cellular processes, including proliferation, survival, growth, nutrient response, migration, invasion, and angiogenesis.
  • Aberrant Akt activation is implicated in various human cancers, notably thyroid malignancies.

Purpose of the Study:

  • To review the role of the Akt pathway in normal thyrocyte proliferation.
  • To elucidate pathogenic mechanisms of aberrant Akt signaling in thyroid cancer.
  • To examine the contribution of Akt substrates to thyroid cancer onset and progression.
  • To discuss current therapeutic strategies targeting the PI3K/Akt pathway in thyroid cancer.

Main Methods:

  • Literature review and synthesis of existing research on Akt signaling in thyroid biology and cancer.
  • Analysis of molecular mechanisms underlying Akt pathway dysregulation in thyroid malignancies.
  • Evaluation of the roles of specific Akt substrates in thyroid cancer pathogenesis.
  • Discussion of preclinical and clinical data on PI3K/Akt inhibitors for thyroid cancer treatment.

Main Results:

  • The Akt pathway significantly influences normal thyrocyte proliferation.
  • Various mechanisms lead to aberrant Akt signaling in thyroid tumors, promoting cancer development.
  • Specific Akt substrates are identified as key contributors to thyroid cancer initiation and progression.
  • Targeting the PI3K/Akt pathway represents a promising therapeutic avenue for thyroid cancer.

Conclusions:

  • The Akt pathway is a critical regulator of thyroid cell function and a key driver of thyroid cancer.
  • Understanding the specific Akt substrates and dysregulation mechanisms is essential for targeted therapy development.
  • Targeting the PI3K/Akt pathway holds significant therapeutic potential for managing thyroid malignancies.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...